{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:55:06Z","timestamp":1773212106969,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jns.2010.07.023","type":"journal-article","created":{"date-parts":[[2010,8,18]],"date-time":"2010-08-18T10:16:46Z","timestamp":1282126606000},"page":"167-169","source":"Crossref","is-referenced-by-count":37,"title":["Pathophysiology of inflammation and tissue injury in multiple sclerosis: What are the targets for therapy"],"prefix":"10.1016","volume":"306","author":[{"given":"Hans","family":"Lassmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2010.07.023_bb0005","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jns.2010.07.023_bb0010","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1016\/j.jns.2010.07.023_bb0015","doi-asserted-by":"crossref","first-page":"14599","DOI":"10.1073\/pnas.0404874101","article-title":"Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines","volume":"101","author":"Hohlfeld","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jns.2010.07.023_bb0020","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1212\/01.wnl.0000344417.42972.54","article-title":"Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes","volume":"72","author":"Wiendl","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2010.07.023_bb0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/WCO.0b013e32832b4ca1","article-title":"Emerging multiple sclerosis disease-modifying therapies","volume":"22","author":"Giacomini","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jns.2010.07.023_bb0030","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1474-4422(08)70173-X","article-title":"Repeated subcutaneous injections of Il12\/23 p40 neutralizing antibody, ustekinumab, in patients with relapsing\u2013remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study","volume":"7","author":"Segal","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2010.07.023_bb0035","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"HERMES Trial Group. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2010.07.023_bb0040","series-title":"Comparative Neuropatholohy of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis","first-page":"1","author":"Lassmann","year":"1983"},{"key":"10.1016\/j.jns.2010.07.023_bb0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000109936","article-title":"Positive and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis","volume":"5","author":"Taoufik","year":"2008","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.jns.2010.07.023_bb0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.192.3.393","article-title":"Clonal expansion of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction","volume":"192","author":"Babbe","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jns.2010.07.023_bb0055","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1073\/pnas.0308689100","article-title":"Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood","volume":"101","author":"Skulina","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jns.2010.07.023_bb0060","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/brain\/awh578","article-title":"Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?","volume":"128","author":"Friese","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jns.2010.07.023_bb0065","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.21363","article-title":"Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open label, phase I trial","volume":"63","author":"Bar-Or","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2010.07.023_bb0070","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jns.2010.07.023_bb0075","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/ncprheum0950","article-title":"Activated B cells in autoimmune disease: the case for a regulatory role","volume":"4","author":"Anderton","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.jns.2010.07.023_bb0080","doi-asserted-by":"crossref","DOI":"10.1007\/s11481-010-9201-3","article-title":"Epstein Barr virus infection and multiple sclerosis","author":"Ascherio","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.jns.2010.07.023_bb0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.jns.2010.07.023_bb0090","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/01.jnen.0000235119.52311.16","article-title":"Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis","volume":"65","author":"Hochmeister","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jns.2010.07.023_bb0095","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jns.2010.07.023_bb0100","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/cncr.25008","article-title":"Central nervous system prophylaxis in adults with acute lymphobrastic leukemia","volume":"116","author":"Jabbour","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2010.07.023_bb0105","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.nurt.2009.04.013","article-title":"Biology and treatment of primary central nervous system lymphoma","volume":"6","author":"Algazi","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jns.2010.07.023_bb0110","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/CAD.0b013e32830cebc1","article-title":"Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma","volume":"19","author":"Villela","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jns.2010.07.023_bb0115","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tins.2010.01.002","article-title":"Multiple sclerosis \u2013 candidate mechanisms underlying CNS atrophy","volume":"33","author":"Sifrin","year":"2010","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jns.2010.07.023_bb0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1474-4422(09)70043-2","article-title":"Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis","volume":"8","author":"Trapp","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2010.07.023_bb0125","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/brain\/awn105","article-title":"Mitochondrial defects in acute multiple sclerosis lesions","volume":"131","author":"Mahad","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jns.2010.07.023_bb0130","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/brain\/awp337","article-title":"Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death","volume":"133","author":"Veto","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jns.2010.07.023_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2005.03.031","article-title":"General mechanisms of axonal damage and its prevention","volume":"133","author":"Stys","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2010.07.023_bb0140","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/brain\/awp046","article-title":"Mitochondrial changes within axons in multiple sclerosis","volume":"132","author":"Mahad","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jns.2010.07.023_bb0145","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.20736","article-title":"Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients","volume":"59","author":"Dutta","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2010.07.023_bb0150","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(09)60442-6","article-title":"Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial","volume":"373","author":"Goodman","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2010.07.023_bb0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-4-30","article-title":"Differential effects of Th1, monocyte\/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation","volume":"4","author":"Lisak","year":"2009","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jns.2010.07.023_bb0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1750-3639.1999.tb00212.x","article-title":"Demyelination: the role of oxygen and nitrogen species","volume":"9","author":"Smith","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jns.2010.07.023_bb0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-510X(00)00343-9","article-title":"Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis","volume":"177","author":"Lu","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2010.07.023_bb0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2008.08.035","article-title":"Elevated myeloperoxidase activity in white matter in multiple sclerosis","volume":"442","author":"Gray","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2010.07.023_bb0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1750-3639.2007.00110.x","article-title":"Elevated activity of microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis","volume":"18","author":"Gray","year":"2008","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jns.2010.07.023_bb0180","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/ana.21582","article-title":"Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron","volume":"64","author":"Hammond","year":"2008","journal-title":"Ann Neurol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X10003461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X10003461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T17:48:18Z","timestamp":1711734498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X10003461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022510X10003461"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2010.07.023","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}